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Multiple endocrine neoplasia type 2B syndrome is rarely reported in Chi-
nese patients. A 25-year-old Chinese male presented with full-blown clinical
features of this syndrome, including bilateral phaeochromocytomas, med-
ullary thyroid carcinoma, and characteristic phenotypic features. One-stage
surgical treatment was performed and subsequent genetic analysis confirmed
a point mutation at codon 918 in exon 16 of the RET proto-oncogene. The
mutation was arising de novo as there was no corresponding mutation found
in both his parents or younger sister. Data published to date suggest there is
no difference in the genetic and pathophysiologic basis, nor clinical charac-
teristics of multiple endocrine neoplasia type 2B in Chinese patients. As the
disease can be lethal, early diagnosis by prompt recognition of the charac-
teristic phenotypic features followed by surgical treatment should improve
the outcome. Family screening is essential to identify at-risk family mem-
bers for prophylactic treatment.
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Introduction
Multiple endocrine neoplasia (MEN) type 2 syndromes, including types 2A and
2B, are inherited endocrine disorders characterised by the presence of medullary
thyroid carcinoma (MTC) and phaeochromocytoma. Multiple endocrine neopla-
sia type 2B is typified by a characteristic phenotype with the occurrence of mul-
tiple mucosal neuromas and a marfanoid habitus. Intestinal ganglioneuromatosis,
corneal nerve thickening, and skeletal abnormalities are often present. Parathy-
roid hyperplasia, a common finding in MEN type 2A, is not a feature of MEN
type 2B.
Multiple endocrine neoplasia type 2B is rarely reported in Chinese patients.
In a review of both the English and Chinese literature, only two Chinese patients
with MEN type 2B had been previously reported.1,2 We report in this case study
the surgical treatment of a 25-year-old Chinese man with a full-blown clinical
picture of MEN type 2B associated with a de novo germline mutation of the RET
proto-oncogene gene.
Case report
A 25-year-old Chinese man studying in Sydney, Australia, presented to a gen-
eral practitioner with throbbing headache associated with an elevated blood
pressure of 240/140 mm Hg. He was referred to the hypertension clinic for
investigation of a possible secondary cause. His past health was unremarkable
except for on-and-off chronic constipation since childhood. His father had a
Hong Kong Med J Vol 10 No 3 June 2004      207
Multiple endocrine neoplasia type 2B
history of hypertension requiring antihypertensive
medication. Physical examination revealed that the
patient, who was tall and had a slender build, possessed
features of marfanoid habitus including a long, thin face
with prognathism, and long limbs. Multiple nodules
were detected in the anterior third of the tongue, buccal
mucosa, and lips suggestive of ganglioneuromatosis. There
was no sign of congestive heart failure. Examination of
the neck showed no palpable lymph node or thyroid
mass while abdominal examination showed a distended
abdomen with grossly dilated and loaded colon. There
was no ascites, hepatosplenomegaly, or ballotable mass.
Per-rectal examination was unremarkable.
In view of the characteristic phenotypic features and the
presence of hypertension, MEN type 2B syndrome was
suspected. A 24-hour urinary collection for fractionated
catecholamines showed significantly elevated levels for
catecholamines and their metabolites, suggestive of
pheochromocytoma. His full blood count, liver and renal
function tests including serum calcium level were all normal.
Results of his thyroid function test were also normal but the
basal calcitonin level was elevated to 29 pmol/L (reference
level, <7.5 pmol/L).
Computed tomography (CT) showed a 6-cm mass and a
suspicious nodule measuring 1 cm at the left and right
adrenal glands, respectively. The ascending and transverse
colons were noted to be markedly dilated and loaded
with faeces. Metaiodobenzylguanidine scintigraphy
confirmed bilateral adrenal involvement and the uptake
was more intense on the left side (Fig 1). Ultrasono-
graphy and CT scan of the neck showed bilateral thyroid
nodules with a mildly enlarged right submandibular
lymph node. Ultrasonography-guided fine-needle
aspiration of the thyroid nodules confirmed the presence
of MTC. However, insufficient aspirate from the sub-
mandibular lymph node prevented the confirmation of
nodal metastasis. The patient was treated with phenoxy-
benzamine followed by propanolol to control his blood
pressure and as part of the preoperative pharmaco-
logical preparation. On receiving a request from the patient
to be treated in Hong Kong, the patient was referred to us
for definitive surgical treatment.
A one-stage operative procedure with laparotomy
and bilateral adrenalectomy followed by cervical explora-
tion was planned. During laparotomy, megacolon
measuring almost 10 cm in diameter was noted at the
ascending and transverse colon. The phaeochromocy-
tomas located at the left and right adrenal glands
measured 7 x 6 x 4 cm and 1 cm, respectively. During
cervical exploration, tumours measuring 1.5 cm and
1 cm were found at the right and left upper poles of thy-
roid gland, respectively. Intra-operative frozen section
confirmed MTC with metastasis to one lateral cervical
lymph node. Total thyroidectomy, and central and
bilateral neck dissection were performed (Fig 2).
Pathology revealed bilateral phaeochromocytomas
and multifocal MTC with multiple cervical nodal
metastases. The patient recovered well after the operation
and was discharged home on postoperative day 8 with
thyroxine, cortisol, fludrocortisone, and calcium supple-
ment. Postoperative direct laryngoscopy showed no
evidence of cord paresis. Repeated 24-hour urinary levels
of catecholamines were all normal. In addition, both his
basal and pentagastrin-stimulated calcitonin levels were
within the normal range.
Genetic analysis confirmed a point mutation from ATG
(Met) to ACG (Thr) at codon 918 in exon 16 of the RET
proto-oncogene but there was no corresponding mutation
found in both his parents or younger sister. Therefore, the
mutation was considered as arising de novo.
Fig 1. A small focus of markedly increased metaiodobenzyl-
guanidine uptake demonstrated in the region of the right
adrenal gland and also a large focus of irregularly increased
uptake in the region of the left adrenal gland as shown in the
24-hour anterior (a) and posterior (b) images post-injection
(a) (b)
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Discussion
Williams and Pollock3 first described the association of
MTC, phaeochromocytoma, and multiple mucosal
neuromas, and this syndrome was termed MEN type 2B in
1975 by Chong et al.4 Multiple endocrine neoplasia
type 2B belongs to a family of heritable endocrine
diseases that include MEN type 1, MEN type 2A, and
familial medullary thyroid carcinoma (FMTC). All MEN
syndromes, including MEN type 2B, demonstrate an
autosomal dominant pattern of inheritance. As with MEN
type 2A and FMTC, MEN type 2B is caused by a defect
in the RET proto-oncogene, which lies in chromosome
10q11.2 and consists of 21 exons. The RET gene is import-
ant in signalling for cell growth and differentiation of
tissues derived from neural crest cells, such as C-cell of
the thyroid gland, the adrenal medulla, the parathyroid
gland, and the enteric autonomous nerve plexus. Chinese
patients with MEN type 2A have been found to have
germline mutations at a hot site in codon 634.5,6 For
MEN type 2B, mutation at codon 883 has been recently
reported in two families7 but over 95% of patients have a
single point mutation in the RET gene, with a substitution
of threonine for methionine at codon 918 in exon 16.
The mutation identified in our patient and in the two
previously reported Chinese patients1,2 is consistent with
that reported from western countries.
In MEN type 2 syndrome, there is essentially complete
penetrance of the genetic defect but with variable
expressivity because not every patient manifests all the
characteristics of this syndrome. Medullary thyroid car-
cinoma is almost always present in all subtypes of MEN
type 2 syndrome while phaeochromocytoma occurs
in 40% to 50% of all patients. Parathyroid hyperplasia
is found in 10% to 20% of patients with MEN type
2A but is invariably absent in MEN type 2B. Compared
with type 2A, which accounts for 90% of MEN type 2
syndromes, the MEN type 2B is less common, presents
at an earlier age, and tends to be more aggressive. The
onset of MEN type 2B normally occurs in patients who
are in their first or second decade of life. Patients with
MEN type 2B also tend to have a poorer prognosis than
those with MEN type 2A or FMTC. Genetic inheritance
accounts for 80% of MEN type 2A patients, while de
novo mutations account for 50% of MEN type 2B patients,
including the three Chinese patients reported. Data
indicate that patients with MEN type 2B are less likely to
reproduce because they die of their disease at an earlier
age.
Surgical treatment of patients with MEN type 2B is
recommended. Total thyroidectomy with central compart-
ment node dissection is the procedure of choice, preferably
on a prophylactic basis at the stage of C-cell hyperplasia
before the formation of invasive MTC. Bilateral neck
dissection should be performed when the central node
shows metastatic involvement because of the high inci-
dence of cervical nodal metastasis. Normocalcitoninaemia
after calcium and pentagastrin stimulation suggests
surgical cure of the MTC. However, thyroidectomy
should not be undertaken until co-existing pheochromo-
cytoma has been excluded or treated to avoid catecho-
lamine crisis. The diagnosis of phaeochromocytoma in
patients with MEN type 2 is not different from that of
sporadic phaeochromocytoma. Alpha-followed by beta-
blockade is preferred for preoperative pharmacological
preparation.
Opinions differ with regard to the management of
the contralateral adrenal gland in patients presenting
with unilateral disease. Bilateral total adrenalectomy
at the time of initial surgery is advocated by some
clinicians since synchronous tumour or adrenal med-
ullary hyperplasia is almost always seen microscopically
in the contralateral gland and the subsequent need for a
second surgical procedure can be avoided. The price to
Fig 2. (a) Operative specimens showing a 6-cm and 1-cm
phaeochromocytoma at the left and right adrenal glands,
respectively; (b) multiple medullary thyroid carcinomas from
1 to 1.5 cm in size located at the upper pole of thyroid gland
as well as the central and bilateral lymphadenectomy
specimens
(a)
(b)
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pay for bilateral total adrenalectomy is life-long post-
operative replacement therapy with adrenal cortical
hormones. Therefore, a selective approach by removing
only the affected adrenal gland and closely monitoring
the contralateral side through annual measurements
of 24-hour fractionated catecholamine is preferred. This
is because not all patients will go on to develop a clin-
ically significant contralateral phaeochromocytoma.
Although laparoscopic adrenalectomy is the preferred
surgical approach,8 open bilateral adrenalectomy was
opted in our patient because of the anticipated technical
difficulty associated with a limited dissection space
caused by the relatively large tumour and the presence of
megacolon.
Gastro-intestinal involvement is not uncommon in
MEN type 2B. Over 90% of patients report a variety of
gastro-intestinal complaints including flatulence, abdom-
inal distension, abdominal pain, constipation, difficulty in
swallowing, and vomiting. It has been reported that
about 30% of patients with MEN type 2B ultimately
need surgery for gastro-intestinal complications.9 Chronic
constipation in patients with MEN type 2B is associated
with gastro-intestinal ganglioneuromatosis while
concomitant Hirschsprung’s disease occurs in patients
with MEN type 2A but not 2B syndrome. Our patient
had on-and-off chronic constipation with bowel move-
ment every 2 to 3 days. Although his colon was grossly
dilated, surgical intervention in the form of subtotal
colectomy will not be attempted unless complications
arise from his megacolon.
Screening is essential to identify asymptomatic carriers
from family members of patients with MEN type 2
syndrome.10 Genetic screening by blood test is the most
cost-effective and least invasive procedure. Genetic analy-
sis is conducted on DNA that has been isolated from
peripheral blood leukocytes and amplified using polymer-
ase chain reaction techniques.10 Direct DNA sequencing
can identify specific mutations of the RET proto-oncogene.
Siblings of patients with MEN type 2B should be
screened as early as 1 year of age since C-cell hyperplasia,
a precursor of MTC, can be present when the patient
is as young as 3 months old. Prophylactic total thyroidec-
tomy before the presence of invasive MTC should be
considered for RET proto-oncogene carriers to improve the
prognosis.
Conclusion
Multiple endocrine neoplasia type 2B is rarely reported
in the Chinese population compared to the findings in
western countries. Based on the published data, there is
no difference in the genetic and pathophysiologic
basis, or clinical characteristics of MEN type 2B in
Chinese patients. As the disease can be aggressive
and is associated with a poor prognosis, early diagnosis
by prompt recognition of the characteristic phenotypic
features followed by an effective surgical treatment
should improve the outcome. Family screening is essential
to identify at-risk family members for early surgical
treatment.
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